Published in World J Surg on September 01, 2009
Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer. World J Surg (2012) 0.89
ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro. J Exp Clin Cancer Res (2011) 0.88
Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer. World J Surg (2013) 0.87
RBP2 induces epithelial-mesenchymal transition in non-small cell lung cancer. PLoS One (2013) 0.83
Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy. World J Surg (2011) 0.82
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors. Virchows Arch (2011) 0.79
MTA1--a stress response protein: a master regulator of gene expression and cancer cell behavior. Cancer Metastasis Rev (2014) 0.77
Overexpression of IFITM3 predicts the high risk of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. PeerJ (2015) 0.75
MTA1 Expression in Benign and Malignant Salivary gland Tumors. Iran J Otorhinolaryngol (2016) 0.75
Role of metastasis-associated protein 1 in prognosis of patients with digestive tract cancers: A meta-analysis. PLoS One (2017) 0.75
Global cancer statistics in the year 2000. Lancet Oncol (2001) 11.11
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol (2001) 2.93
A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem (1994) 2.90
Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer (2002) 2.82
Emerging roles of MTA family members in human cancers. Semin Oncol (2003) 1.99
Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg (1998) 1.69
The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res (2004) 1.45
Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg (2001) 1.39
Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg (2007) 1.30
Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis (2003) 1.30
Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer (2004) 1.16
Metastasis-associated protein (MTA)1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene (2002) 1.08
Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology (2008) 1.07
Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. J Biol Chem (2002) 1.07
Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br J Cancer (2004) 1.05
Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem (2000) 1.04
MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci (2006) 1.03
Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol (2006) 0.95
Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today (2007) 0.94
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat (2005) 0.88
N1 esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg (2001) 0.87
Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg (2002) 0.78
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet (2010) 2.95
Enhanced mechanical properties of nanocomposites at low graphene content. ACS Nano (2009) 2.12
Fracture and fatigue in graphene nanocomposites. Small (2010) 1.94
Measurement of flow modification in phantom aneurysm model: comparison of coils and a longitudinally and axially asymmetric stent--initial findings. Radiology (2004) 1.84
Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Ann Thorac Surg (2009) 1.61
Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer Res (2003) 1.61
High-level CXCR4 expression correlates with brain-specific metastasis of non-small cell lung cancer. World J Surg (2011) 1.58
Retracted STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells. BMC Cancer (2014) 1.54
Intracellular distribution of TiO2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity. Nano Lett (2007) 1.43
Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem (2003) 1.42
Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol Endocrinol (2011) 1.32
Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg (2007) 1.30
Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak. Mol Cancer Ther (2007) 1.29
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet (2012) 1.28
Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem (2010) 1.24
The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells. Prostate (2007) 1.20
HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. Mol Endocrinol (2009) 1.15
Sagittal alignment of spine and pelvis in asymptomatic adults: norms in Chinese populations. Spine (Phila Pa 1976) (2014) 1.14
Contrast settling in cerebral aneurysm angiography. Phys Med Biol (2005) 1.13
Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model. Prostate (2006) 1.12
An in vivo model to study and manipulate the hematopoietic stem cell niche. Blood (2010) 1.11
The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia. Prostate (2009) 1.08
Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocrine (2010) 1.08
On the mathematical properties of the structural similarity index. IEEE Trans Image Process (2011) 1.07
Video saliency incorporating spatiotemporal cues and uncertainty weighting. IEEE Trans Image Process (2014) 1.06
Differential regulation of clusterin and its isoforms by androgens in prostate cells. J Biol Chem (2006) 1.06
Vessel size measurements in angiograms: a comparison of techniques. Med Phys (2002) 1.05
ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation. Prostate (2006) 1.05
U19/Eaf2 binds to and stabilizes von hippel-lindau protein. Cancer Res (2009) 1.04
Complex wavelet structural similarity: a new image similarity index. IEEE Trans Image Process (2009) 1.03
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials (2012) 1.03
The 100% Condom Use Program: a demonstration in Wuhan, China. Eval Program Plann (2007) 1.01
Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Clin Cancer Res (2005) 1.01
Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain. Prostate (2007) 0.99
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo. Int J Cancer (2007) 0.99
Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology (2003) 0.98
Identification and characterization of PLZF as a prostatic androgen-responsive gene. Prostate (2004) 0.97
Expression and function of the human androgen-responsive gene ADI1 in prostate cancer. Neoplasia (2007) 0.95
USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2012) 0.95
Optimization of alkaline extraction of polysaccharides from Ganoderma lucidum and their effect on immune function in mice. Molecules (2010) 0.95
Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin. Int J Cancer (2005) 0.95
Bilateral adrenal tumor: causes and clinical features in eighteen cases. Int Urol Nephrol (2008) 0.94
Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today (2007) 0.94
CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Ann Surg Oncol (2012) 0.93
EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate. Angiogenesis (2011) 0.93
Vessel size measurements in angiograms: manual measurements. Med Phys (2003) 0.93
Suppressive roles of calreticulin in prostate cancer growth and metastasis. Am J Pathol (2009) 0.93
EAF2 suppresses hypoxia-induced factor 1α transcriptional activity by disrupting its interaction with coactivator CBP/p300. Mol Cell Biol (2014) 0.92
Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation. J Biol Chem (2009) 0.92
Potential gene flow of two herbicide-tolerant transgenes from oilseed rape to wild B. juncea var. gracilis. Theor Appl Genet (2010) 0.92
Prolongation of off-cycle interval by finasteride is not associated with survival improvement in intermittent androgen deprivation therapy in LNCaP tumor model. Prostate (2010) 0.92
Concentrations of PCDD/PCDFs and PCBs in retail foods and an assessment of dietary intake for local population of Shenzhen in China. Environ Int (2008) 0.91
Gadd45gamma is androgen-responsive and growth-inhibitory in prostate cancer cells. Mol Cell Endocrinol (2004) 0.89
Digoxin inhibits blood vessel density and HIF-1a expression in castration-resistant C4-2 xenograft prostate tumors. Clin Transl Sci (2012) 0.89
Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance. Prostate (2011) 0.89
Identification and characterization of an androgen-responsive gene encoding an aci-reductone dioxygenase-like protein in the rat prostate. Endocrinology (2003) 0.89
STAT3 expression correlates with prognosis of thymic epithelial tumors. J Cardiothorac Surg (2013) 0.88
Objective quality assessment of tone-mapped images. IEEE Trans Image Process (2012) 0.88
Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. Prostate (2010) 0.87
FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells. Prostate (2015) 0.86
Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo. J Transl Med (2013) 0.86
[Advances on micrometastasis of Non-small Cell Lung Cancer.]. Zhongguo Fei Ai Za Zhi (2009) 0.85
Abdominal lymph node metastasis in patients with mid thoracic esophageal squamous cell carcinoma. World J Surg (2009) 0.85
Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation. Prostate (2013) 0.85
Protective effects of selenium on oxidative damage and oxidative stress related gene expression in rat liver under chronic poisoning of arsenic. Food Chem Toxicol (2013) 0.85
Sagittal spinopelvic alignment in adolescents associated with Scheuermann's kyphosis: a comparison with normal population. Eur Spine J (2014) 0.84
Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation. Endocrinology (2012) 0.84
Androgen regulation of spermidine synthase expression in the rat prostate. Prostate (2002) 0.84
Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse. J Gastroenterol Hepatol (2014) 0.84
Core-shell nanostructured "black" rutile titania as excellent catalyst for hydrogen production enhanced by sulfur doping. J Am Chem Soc (2013) 0.84
STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Ann Surg Oncol (2013) 0.84
5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models. Endocrinology (2013) 0.83
Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate. Cancer Microenviron (2013) 0.83
Cytoplasmic localization of the androgen receptor is independent of calreticulin. Mol Cell Endocrinol (2008) 0.83
Management and surgical resection for tumors of the trachea and carina: experience with 32 patients. World J Surg (2009) 0.83
N-terminal domain of the androgen receptor contains a region that can promote cytoplasmic localization. J Steroid Biochem Mol Biol (2013) 0.83
Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy. World J Surg (2011) 0.82
Super-low friction and super-elastic hydrogenated carbon films originated from a unique fullerene-like nanostructure. Nanotechnology (2008) 0.82
Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer. Eur J Cardiothorac Surg (2009) 0.81
Molecular signature and in vivo behavior of bone marrow endosteal and subendosteal stromal cell populations and their relevance to hematopoiesis. Exp Cell Res (2012) 0.81
Therapeutic efficacy comparison of two surgical procedures to treat middle thoracic esophageal carcinoma. World J Surg (2010) 0.81
Prognostic factors of patients with thymic carcinoma after surgery: a retrospective analysis of 58 cases. World J Surg (2014) 0.81
Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis. Int Urol Nephrol (2015) 0.81
New development of inhibitors targeting the PI3K/AKT/mTOR pathway in personalized treatment of non-small-cell lung cancer. Anticancer Drugs (2015) 0.81
Overexpression of RUNX3 inhibits malignant behaviour of Eca109 cells in vitro and vivo. Asian Pac J Cancer Prev (2014) 0.81
Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes. J Biol Chem (2011) 0.81
ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells. Prostate (2010) 0.81
Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-lewis esophagectomy in esophageal cancer. Ann Surg Oncol (2013) 0.81
[Effects of 5-fluorouracil on tendon adhesion formation after flexor tendon repair]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2008) 0.81
Gray TiO2 nanowires synthesized by aluminum-mediated reduction and their excellent photocatalytic activity for water cleaning. Chemistry (2013) 0.81
Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients. Diagn Pathol (2014) 0.80
Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism. Biochem Biophys Res Commun (2004) 0.80
Lymph node occult micrometastasis in patients with non-small cell lung carcinoma: genetic diagnosis and its impact on prognosis. Ai Zheng (2003) 0.80
Potential gene flow from transgenic rice (Oryza sativa L.) to different weedy rice (Oryza sativa f. spontanea) accessions based on reproductive compatibility. Pest Manag Sci (2009) 0.80